Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer.

Chemoresistance is a principal cause of treatment failure in bladder cancer (BLCA), yet the mechanisms that actively maintain resistance remain poorly defined. Gemcitabine (GEM) resistance is classically attributed to impaired drug uptake via human equilibrative nucleoside transporter 1 (hENT1) and activation of pro-su...

Yunyi Liu, Ya-Tao Wu, Juan Li et al. · 0 citations
Open access Sep 2026

CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target

This work identifies CaM kinase-like vesicle-associated protein (CAMKV) as a MYCN/MYC-regulated effector of NB pathogenesis and establishes CAMKV as a central signaling hub that coordinates metabolic and proliferative pathways.

Yang Yu, Yan-Ling Zhao, Zhong-Cheng Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.